Guoqian Venture Capital
VC Fund
Haimen, China
Guoqian Venture Capital is a VC fund in Haimen focused on Medical and Health Care. Guoqian Venture Capital focuses on the equity investment in the early and middle stage of start-ups in the medical devices, which is an important step to implement the strategic roadmap “Industry + Capital”.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Guoqian Venture Capital invests in
Stages Guoqian Venture Capital invests in
Countries Guoqian Venture Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 8 (57%)
- Health Care 6 (43%)
- Biotechnology 6 (43%)
- Manufacturing 6 (43%)
- Pharmaceutical 3 (21%)
Stage
- Series B 4 (29%)
- Angel 3 (21%)
- Series A 3 (21%)
- Seed 2 (14%)
- Venture - Series Unknown 2 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chen Hao
Partner
|
Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Jiangsu Junhua
|
Jiangsu Junhua is an engineering plastics manufacturer specializing in the research and development of high-performance special engineering plastic parts and profiles like PEEK and PI. | Venture - Series Unknown / Aug 12, 2024 | |
Insaifeiying
|
Insaifeiying is a manufacturer of innovative medical equipment for minimally invasive surgery. It focuses on the research, development, and manufacturing of intelligent wireless endoscopes. | Seed / Mar 18, 2024 | |
Yunmao Technology
|
Yunmao Technology develops precision nano-coating equipment for semiconductor chip manufacturing. | Series B / Jun 27, 2023 | |
Baikang Bio
|
Baikang Bio is an in vitro diagnostic and upstream core raw material developer of biological drugs. | $13.4M / Series A / Jan 12, 2023 | |
Bioantibody
|
Bioantibody is a high-tech biotechnology firm specializing in the research and development of antigens, antibodies, and downstream detection reagents for diagnosis and therapy. | $14.8M / Series A / Jan 12, 2023 | |
Nenstar Electronic Technology
|
Leanstar Sensor has developed the core design capabilities of multi-variety and multi-range flexible micro-nano mechanical force sensors. Their products are flexible pressure sensors, flexible piezoelectric sensors, flexible capacitive sensors, flexible thermal sensors, flexible temperature and humidity sensors, and flexible integrated compositemicro-nano sensors. | Venture - Series Unknown / Apr 29, 2022 | |
BIOSURF
|
BIOSURF is an innovation-driven healthcare based surface modification technology company. | $15.7M / Series B / Apr 15, 2022 | |
Keyto
|
Keyto specializes in the production of key electrical and mechanical components for microfluid system controls. | Series B / Jan 22, 2021 | |
MagAssist
|
Suzhou Xinqing Medical Technology Co., Ltd. was founded in 2017 by Dr. Xu Bozhen, a special expert of the National Youth Thousand People Program and a special professor of Suzhou University. He is a high-tech enterprise with the main goal of developing the world's leading in vitro short-term ventricular assist device (in vitro artificialheart). . The core members of the company's entrepreneurial team are the world's top artificial heart engineering technology experts. With years of experience in overseas artificial heart research and development and productization, the company has developed a domestically produced artificial heart with independent intellectual property rights. | $15.4M / Series B / Jan 14, 2021 | |
Dima Biotech
|
Dima Biotech is a tumor immunotherapy and monoclonal antibody developer, specializing in the development of recombinant monoclonal antibodies for tumor immune products and services. It has the unique RECmAb digital monoclonal antibody technology, which can be used to obtain a variety of genus and high quality. Monoclonal antibodies. | Angel / Sep 11, 2019 | |
| See all 14 investments → | |||
Co-Investors
Huatai Zijin Investment
3 deals together
Bondshine Capital
2 deals together
Fang Fund Partners
2 deals together
BridgeOne Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Guoqian Venture Capital invest in?
Guoqian Venture Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B and Angel stage. Most of the 14 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Guoqian Venture Capital?
Public channels for Guoqian Venture Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Guoqian Venture Capital?
The team at Guoqian Venture Capital includes Chen Hao (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
